Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Oct;94(4):1657–1661. doi: 10.1172/JCI117509

Self-induced correction of the genetic defect in tyrosinemia type I.

E A Kvittingen 1, H Rootwelt 1, R Berger 1, P Brandtzaeg 1
PMCID: PMC295327  PMID: 7929843

Abstract

A mosaic pattern of immunoreactive fumarylacetoacetase (FAH) protein was found in liver tissue in 15 of 18 tyrosinemia type I patients of various ethnic origins. One additional patient had variable levels of FAH enzyme activity in liver tissue. In four patients exhibiting mosaicism of FAH protein, analysis for the tyrosinemia-causing mutations was performed in immunonegative and immunopositive areas of liver tissue by restriction digestion analysis and direct DNA sequencing. In all four patients the immunonegative liver tissue contained the FAH mutations demonstrated in fibroblasts of the patients. In the immunopositive nodules of regenerating liver tissue one of the mutated alleles apparently had reverted to the normal genotype. This genetic correction was observed for three different tyrosinemia-causing mutations. In each case a mutant AT nucleotide pair was reverted to a normal GC pair.

Full text

PDF
1657

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fuchs R. P. DNA binding spectrum of the carcinogen N-acetoxy-N-2-acetylaminofluorene significantly differs from the mutation spectrum. J Mol Biol. 1984 Jul 25;177(1):173–180. doi: 10.1016/0022-2836(84)90063-9. [DOI] [PubMed] [Google Scholar]
  2. Grompe M., al-Dhalimy M. Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I. Hum Mutat. 1993;2(2):85–93. doi: 10.1002/humu.1380020205. [DOI] [PubMed] [Google Scholar]
  3. Kvittingen E. A., Rootwelt H., Brandtzaeg P., Bergan A., Berger R. Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect. J Clin Invest. 1993 Apr;91(4):1816–1821. doi: 10.1172/JCI116393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Macvicar D., Dicks-Mireaux C., Leonard J. V., Wight D. G. Hepatic imaging with computed tomography of chronic tyrosinaemia type 1. Br J Radiol. 1990 Aug;63(752):605–608. doi: 10.1259/0007-1285-63-752-605. [DOI] [PubMed] [Google Scholar]
  5. Seeberg E., Fuchs R. P. Acetylaminofluorene bound to different guanines of the sequence -GGCGCC- is excised with different efficiencies by the UvrABC excision nuclease in a pattern not correlated to the potency of mutation induction. Proc Natl Acad Sci U S A. 1990 Jan;87(1):191–194. doi: 10.1073/pnas.87.1.191. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES